Trial reportFrontiers in neurology2025
Uni-hemispheric dual-site anodal tDCS (M1-DLPFC) for upper limb motor function and spasticity in chronic stroke: a randomized clinical trial.
Trial report in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/objectives: Upper extremity impairment significantly affects motor function and quality of life after stroke. This study investigated the safety and efficacy of a non-invasive brain stimulation approach, uni-hemispheric concurrent dual-site anodal transcranial direct current stimulation (a-tDCS) targeting the primary motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC), to improve upper extremity performance in chronic stroke. Methods: This double-blind, randomized, sham-controlled study involved 38 chronic stroke patients to evaluate the safety and efficacy of uni-hemispheric concurrent dual-site anodal transcranial direct current stimulation (a-tDCS). Participants were randomly assigned to one of two groups: experimental group 1 (a-tDCS at 2 mA targeting M1 and DLPFC concurrently) or experimental group 2 (active a-tDCS at 2 mA over M1 with sham stimulation over DLPFC), with each receiving 20-min sessions over five consecutive days. Upper extremity motor function (Fugl-Meyer Assessment-FMA) and spasticity (Modified Modified Ashworth Scale-MMAS) were assessed at baseline and 24 h following the final intervention. The procedure was deemed safe. Statistical analysis involved the U Mann-Whitney test for between-group comparisons and the Wilcoxon signed-rank test for within-group changes. Results: The results demonstrated that uni-hemispheric concurrent dual-site a-tDCS targeting M1 and DLPFC in experimental group 1 did not lead to statistically significant improvements in upper extremity motor function, elbow and wrist flexor spasticity, or range of motion in this cohort of chronic stroke patients. Furthermore, no statistically significant differences were found between experimental group 1 and experimental group 2 (the sham control group) for any of the measured outcomes ( Conclusion: Uni-hemispheric concurrent dual-site a-tDCS targeting both M1 and DLPFC did not demonstrate a superior effect on upper extremity motor recovery compared to a-tDCS applied solely to M1 in chronic stroke patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.